19018 Federal Register / Vol. 77, No. 61 / Thursday, March 29, 2012 / Notices 

Act of 2000 to advise the President on a 

variety of policy and technical functions 

required to implement and effectively 

manage the new compensation program. Key 

functions of the Advisory Board include 

providing advice on the development of 

probability of causation guidelines, which 

have been promulgated by the Department of 

Health and Human Services (HHS) as a final 

rule; advice on methods of dose 

reconstruction, which have also been 

promulgated by HHS as a final rule; advice 

on the scientific validity and quality of dose 

estimation and reconstruction efforts being 

performed for purposes of the compensation 

program; and advice on petitions to add 

classes of workers to the Special Exposure 

Cohort (SEC). 

In December 2000, the President delegated 

responsibility for funding, staffing, and 

operating the Advisory Board to HHS, which 

subsequently delegated this authority to the 

CDC. NIOSH implements this responsibility 

for CDC. The charter was issued on August 

3, 2001, renewed at appropriate intervals, 

most recently, August 3, 2011, and will 

expire on August 3, 2013. 

Purpose: This Advisory Board is charged 

with (a) providing advice to the Secretary, 

HHS, on the development of guidelines 

under Executive Order 13179; (b) providing 

advice to the Secretary, HHS, on the 

scientific validity and quality of dose 

reconstruction efforts performed for this 

program; and (c) upon request by the 

Secretary, HHS, advising the Secretary on 

whether there is a class of employees at any 

Department of Energy facility who were 

exposed to radiation but for whom it is not 

feasible to estimate their radiation dose, and 

on whether there is reasonable likelihood 

that such radiation doses may have 

endangered the health of members of this 

class. 

Matters To Be Discussed: The agenda for 

the conference call includes: SEC Petition for 

Feed Materials Production Center (Fernald, 

Ohio); Subcommittee and Work Group 

Updates; SEC Petition Evaluations Update for 

the June 2012 Advisory Board Meeting; and 

Board Correspondence. 

The agenda is subject to change as 

priorities dictate. 

Because there is not a verbal public 

comment period, written comments may be 

submitted. Any written comments received 

will be included in the official record of the 

meeting and should be submitted to the 

contact person below in advance of the 

meeting. 

Contact Person for More Information: 

Theodore M. Katz, M.P.A., Designated 

Federal Officer, NIOSH, CDC, 1600 Clifton 

Road NE., Mailstop: E–20, Atlanta, Georgia 

30333, Telephone (513)533–6800, Toll Free 

1(800) CDC–INFO, Email ocas@cdc.gov. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: March 22, 2012. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2012–7554 Filed 3–28–12; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Committee to the Director 

(ACD), Centers for Disease Control and 

Prevention (CDC) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the CDC announces 

the following meeting of the 

aforementioned committee. 

Time and Date: 8:30 a.m.–3 p.m. (EDT), 

April 26, 2012. 

Place: CDC, 1600 Clifton Road NE., 

Building 21, Rooms 1204 A/B, Atlanta, 

Georgia 30333. This meeting is also available 

by teleconference. Please dial (877) 930–8819 

and enter code 1579739. 

Status: Open to the public, limited only by 

the space available. The meeting room 

accommodates approximately 50 people. To 

accommodate public participation in the 

meeting, a conference telephone line will be 

available. The public is welcome to 

participate during the public comment 

period. The public comment period is 

tentatively scheduled from 2:45 p.m. until 

2:50 p.m. 

Purpose: The committee will provide 

advice to the CDC Director on strategic and 

other broad issues facing CDC. 

Matters To Be Discussed: The Advisory 

Committee to the Director will receive 

updates from the Global Workgroup; State, 

Tribal, Local and Territorial Workgroup; the 

Policy Workgroup; the Communications 

Workgroup; the Ethics Subcommittee, and 

the Health Disparities Subcommittee, as well 

as an update from the CDC Director. 

Agenda items are subject to change as 

priorities dictate. 

Contact Person for More Information: 

Carmen Villar, MSW, Designated Federal 

Officer, Advisory Committee to the Director, 

CDC, 1600 Clifton Road NE., M/S D–14, 

Atlanta, Georgia 30333, telephone 404/639– 

7000, email: GHickman@cdc.gov. The 

deadline for notification of attendance is 

April 20, 2012. To register for this meeting, 

please send an email to ACDirector@cdc.gov. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: March 23, 2012. 

Elizabeth Millington, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. 2012–7551 Filed 3–28–12; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Initial Review 

The meeting announced below 

concerns Conducting Public Health 

Research in South Africa, Funding 

Opportunity Announcement (FOA) 

GH12–004, initial review. 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Time and Date: 12 p.m.–4 p.m., May 2, 

2012 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c) (4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters To Be Discussed: The meeting will 

include the initial review, discussion, and 

evaluation of applications received in 

response to ‘‘Conducting Public Health 

Research in South Africa, FOA GH12–004.’’ 

Contact Person for More Information: Lata 

Kumar, Scientific Review Officer, CGH 

Science Office, Center for Global Health, 

CDC, 1600 Clifton Road NE., Mailstop D–69, 

Atlanta, Georgia 30033, Telephone (404) 

639–7618. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: March 22, 2012. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2012–7545 Filed 3–28–12; 8:45 am] 

BILLING CODE 4163–18–P 

mstockstill on DSK4VPTVN1PROD with NOTICES